2025-10-19 - Analysis Report
Okay, here's an analysis of Exxon Mobil (XOM) based on the provided data, formatted for a concise English report:

## Exxon Mobil (XOM) Stock Analysis

**Company Overview:** Exxon Mobil Corp is an integrated oil and gas company that explores for and produces crude oil and natural gas.

### 1. Performance vs. S&P 500 (VOO)

*   **XOM Cumulative Return:** 17.14%
*   **VOO Cumulative Return:** 97.05%
*   **Absolute Divergence:** -79.2 (XOM significantly underperformed VOO)
*   **Relative Divergence:** 16.4 (XOM's performance is in the lower range of its historical divergence compared to VOO).

**Analysis of Alpha, Beta, CAGR, MDD (Rolling 3-Year Periods):**

| Year       | CAGR    | MDD     | Alpha   | Beta   | Cap(B) |
|------------|---------|---------|---------|--------|--------|
| 2015-2017  | 9.0%    | 65.6%   | -19.0%  | 0.0    | 356.6  |
| 2016-2018  | -5.0%   | 71.1%   | -21.0%  | 0.1    | 290.7  |
| 2017-2019  | -6.0%   | 71.1%   | -28.0%  | -0.5   | 297.5  |
| 2018-2020  | -34.0%  | 78.8%   | -57.0%  | -0.4   | 175.7  |
| 2019-2021  | -3.0%   | 78.8%   | -49.0%  | -0.9   | 260.9  |
| 2020-2022  | 48.0%   | 81.8%   | 48.0%   | -0.1   | 470.2  |
| 2021-2023  | 39.0%   | 81.8%   | 37.0%   | 0.5    | 426.2  |
| 2022-2024  | 7.0%    | 81.8%   | -13.0%  | 0.8    | 458.6  |
| 2023-2025  | -21.0%  | 77.7%   | -82.0%  | 1.3    | 478.5  |

*   **CAGR:** Varies significantly across periods, reflecting oil price volatility. Recent periods show declining growth.
*   **MDD:** High Maximum Drawdown values indicate substantial risk.
*   **Alpha:**  Generally negative, implying underperformance relative to its risk-adjusted benchmark, except in 2020-2023.
*   **Beta:** Fluctuates, with recent values suggesting increasing correlation with the market.
*   **Capitalization:**  Shows significant volatility over the analyzed periods.

**Conclusion:** Exxon Mobil has significantly underperformed the S&P 500. The Alpha and Beta values highlight periods of both underperformance and correlation with the market.

### 2. Recent Stock Price Movement

*   **Current Price:** \$112.24
*   **Previous Close:** \$110.64
*   **Change:** \$1.45 (Positive, indicating an upward price movement.)
*   **5-day Moving Average:** 111.80
*   **20-day Moving Average:** 112.97
*   **60-day Moving Average:** 111.22

**Analysis:** The current price is above the 5-day and 60-day moving averages but slightly below the 20-day moving average.  The recent price increase suggests a short-term upward trend.

### 3. Technical Indicators and Market Risk

*   **Market Risk Indicator (MRI):** 0.5 (Low Investment - approaching a "Very Risky" rating)
*   **RSI:** 48.08 (Neutral, not overbought or oversold)
*   **PPO:** -0.26 (Slightly negative, indicating a potential downtrend.)
*   **Hybrid Signal:** "cash_0%_Buy 100% of cash (9 shares - Very Safe - MRI:0.90)" suggests a strong buy recommendation.
*   **Recent (20-day) Relative Divergence Change:** 0.0 (Neutral - no significant recent change)
*   **Expected Return:** -130.7% (Significant underperformance vs. S&P 500 is expected)
*   **Analysis:** The MRI suggests caution, while the RSI is neutral. The PPO suggests a possible downtrend, and the significant change between the Hybrid Signal and the Expected Return is something to carefully consider.

The significant price increase from the previous close (change of \$1.45) indicates a possible 급반등.

### 4. Recent News & Events

*   **Key Headlines:**
    *   Exxon Mobil Evaluating Current Valuation After Recent Share Price Recovery
    *   Catalysts Shaping the Changing Narrative for Exxon Mobil Investors
    *   Exxon Mobil Surpasses Market Returns: Some Facts Worth Knowing
    *   Sector Update: Energy Stocks Advance Late Afternoon
    *   Exxon Mobil Sells Guyanese Crude Oil to Indian Refiners

**Analysis:** Recent news is mixed, with some articles suggesting positive momentum ("Surpasses Market Returns," "Share Price Recovery") and others focusing on valuation ("Evaluating Current Valuation") and changing narratives, a possible turn of the market. The sale of Guyanese crude oil indicates ongoing operational activities.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean Rating: 2.25)
*   **Opinions:** 26 Analysts
*   **Target Price:**
    *   Average: \$126.16
    *   High: \$156.00
    *   Low: \$105.00
*   **Recent Rating Changes:** No specific rating changes provided.

**Analysis:**  Analysts, on average, recommend a "Buy" for XOM, with a considerable upside potential based on the average target price. However, the range of target prices is wide, indicating uncertainty.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 예상 EPS |
|------------|------|----------|
| 2025-08-01 | 1.64 | 1.57     |
| 2025-05-02 | 1.76 | 1.75     |
| 2025-01-31 | 1.67 | 1.77     |
| 2024-11-01 | 1.92 | 1.88     |
| 2024-08-02 | 2.14 | 2.01     |

**Analysis:**  Exxon Mobil has generally met or slightly exceeded EPS expectations in recent quarters, suggesting solid performance.

### 6. Financial Information

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-06-30   | \$79.48B  | 22.58%        |
| 2025-03-31   | \$81.06B  | 22.80%        |
| 2024-12-31   | \$81.06B  | 21.28%        |
| 2024-09-30   | \$87.79B  | 23.23%        |
| 2024-06-30   | \$89.99B  | 22.44%        |

| Quarter      | Equity      | ROE     |
|--------------|-------------|---------|
| 2025-06-30   | \$262.59B   | 2.70%   |
| 2025-03-31   | \$262.72B   | 2.94%   |
| 2024-12-31   | \$263.70B   | 2.89%   |
| 2024-09-30   | \$268.59B   | 3.21%   |
| 2024-06-30   | \$268.40B   | 3.44%   |

**Analysis:** Revenue has declined slightly in recent quarters, but profit margins remain healthy. Equity is relatively stable, while ROE has shown a slight downward trend.

### 7. Overall Assessment

Exxon Mobil has underperformed the S&P 500 significantly in the period examined. While recent earnings have been solid and analyst opinions are generally positive, technical indicators (MRI, PPO) suggest caution. Recent news hints at both recovery and valuation concerns. The negative expected return over the next two years is a significant red flag.
